EQUINOX NEPREMICNINE d.d. Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Rental Revenue	8.73	8.69	7.63	7.15	6.51	5.98
Other Revenue	0.7	0.69	1.04	0.63	0.84	0.73
Total Revenue	9.43	9.37	8.67	7.79	7.34	6.71
Revenue Growth (YoY	1.54%	8.10%	11.35%	6.03%	9.38%	-
Property Expenses	1.71	1.69	2.1	1.62	2.42	2.08
Depreciation & Amortization	3.73	3.81	3.93	3.76	3.41	3.43
Other Operating Expenses	1.5	1.51	2.33	2.04	0.11	0.76
Total Operating Expenses	6.94	7.01	8.36	7.42	5.94	6.27
Operating Income	2.49	2.36	0.31	0.37	1.4	0.45
Interest Expense	-0.43	-0.45	-0.51	-0.64	-0.85	-0.33
Interest & Investment Income	1.26	1.34	1.58	1.24	0.3	0.19
Other Non-Operating Income	-0	-0	0	0	0	0.07
EBT Excluding Unusual Items	3.33	3.25	1.38	0.97	0.85	0.38
Asset Writedown	0.01	0.01	0	-	-	-
Pretax Income	3.34	3.26	1.38	0.97	0.85	0.38
Income Tax Expense	0.88	0.88	0.31	0.1	0.14	-0.16
Net Income	2.46	2.38	1.07	0.87	0.71	0.54
Net Income to Common	2.46	2.38	1.07	0.87	0.71	0.54
Net Income Growth	71.31%	122.71%	23.11%	22.07%	31.87%	-
Basic Shares Outstanding	2	2	2	2	2	-
Diluted Shares Outstanding	2	2	2	2	2	-
Shares Change (YoY)	-	0.09%	-1.51%	1.73%	-	-
EPS (Basic)	1.38	1.34	0.60	0.48	0.40	-
EPS (Diluted)	1.38	1.34	0.60	0.48	0.40	-
EPS Growth	-	122.50%	25.00%	20.00%	-	-
Dividend Per Share	-	-	1.830	1.690	1.430	-
Dividend Growth	-	-	8.28%	18.18%	-	-
Operating Margin	26.44%	25.20%	3.60%	4.72%	19.11%	6.68%
Profit Margin	26.07%	25.42%	12.34%	11.16%	9.70%	8.04%
EBITDA	6.27	6.17	4.25	4.13	4.81	3.88
EBITDA Margin	66.52%	65.85%	48.96%	53.05%	65.54%	57.83%
D&A For Ebitda	3.78	3.81	3.93	3.76	3.41	3.43
EBIT	2.49	2.36	0.31	0.37	1.4	0.45
EBIT Margin	26.44%	25.20%	3.60%	4.72%	19.11%	6.68%
Effective Tax Rate	26.29%	26.90%	22.30%	10.49%	16.20%	-
Revenue as Reported	9.43	9.37	8.67	7.79	7.34	-